MENU
+Compare
SWOBY
Stock ticker: OTC
AS OF
Oct 17 closing price
Price
$16.05
Change
-$0.02 (-0.12%)
Capitalization
11.35B

SWOBY Swedish Orphan Biovitrum AB Forecast, Technical & Fundamental Analysis

Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology... Show more

SWOBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SWOBY with price predictions
Oct 17, 2025

SWOBY sees MACD Histogram just turned negative

SWOBY saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 14, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 19 instances where the indicator turned negative. In of the 19 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SWOBY moved out of overbought territory on October 13, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 similar instances where the indicator moved out of overbought territory. In of the 14 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on October 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SWOBY as a result. In of 30 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

SWOBY broke above its upper Bollinger Band on October 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 23 cases where SWOBY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

SWOBY moved above its 50-day moving average on October 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for SWOBY moved above the 200-day moving average on September 30, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 69 cases where SWOBY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.685) is normal, around the industry mean (17.681). P/E Ratio (24.114) is within average values for comparable stocks, (72.923). Projected Growth (PEG Ratio) (1.533) is also within normal values, averaging (2.078). Dividend Yield (0.034) settles around the average of (0.030) among similar stocks. P/S Ratio (3.914) is also within normal values, averaging (46.505).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SWOBY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SWOBY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
SWOBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Tomtebodavagen 23 A
Phone
+46 86972000
Employees
1831
Web
https://www.sobi.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RMOP25.280.08
+0.32%
Rockefeller Opportunistic Muncpl Bd ETF
ISEP32.000.05
+0.16%
Innovator Intl Dev Pwr Bffr ETF - Sept
GSY50.36N/A
N/A
Invesco Ultra Short Duration ETF
EAD6.81-0.01
-0.15%
Allspring Income Opportunities Fund
DEFI120.40-2.10
-1.71%
Hashdex Bitcoin ETF

Groups containing SWOBY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SWOBY
1D Price
Change %
SWOBY100%
-0.19%
Pharmaceuticals: Generic
industry (219 stocks)
-3%
Poorly correlated
-0.27%
Pharmaceuticals
industry (383 stocks)
-5%
Poorly correlated
-0.25%